Guidelines for the implementation of drug utilization observation (DUO) studies in psychopharmacological therapy. The "Phase IV Research" Task-Force of the Association for Neuropsychopharmacology and Pharmacopsychiatry (AGNP).
Linden, M
Guidelines for the implementation of drug utilization observation (DUO) studies in psychopharmacological therapy. The "Phase IV Research" Task-Force of the Association for Neuropsychopharmacology and Pharmacopsychiatry (AGNP). [electronic resource] - Pharmacopsychiatry Jan 1997 - 65-70 p. digital
Publication Type: Guideline; Journal Article
0176-3679
10.1055/s-2007-979520 doi
Clinical Trials, Phase IV as Topic--legislation & jurisprudence
Drug Utilization Review--legislation & jurisprudence
Epidemiologic Methods
Ethics, Institutional
European Union
Humans
Psychotropic Drugs--adverse effects
Research Design
Guidelines for the implementation of drug utilization observation (DUO) studies in psychopharmacological therapy. The "Phase IV Research" Task-Force of the Association for Neuropsychopharmacology and Pharmacopsychiatry (AGNP). [electronic resource] - Pharmacopsychiatry Jan 1997 - 65-70 p. digital
Publication Type: Guideline; Journal Article
0176-3679
10.1055/s-2007-979520 doi
Clinical Trials, Phase IV as Topic--legislation & jurisprudence
Drug Utilization Review--legislation & jurisprudence
Epidemiologic Methods
Ethics, Institutional
European Union
Humans
Psychotropic Drugs--adverse effects
Research Design